Clinical Trials Directory

Trials / Unknown

UnknownNCT02991365

Effect of Weight Loss on Brain Insulin Sensitivity in Humans

Effekt Von Gewichtsabnahme Auf Die zentralnervöse Insulinresistenz Des Menschen

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

Obesity if known to be associated with brain insulin resistance in humans. This condition has not only implication for the brain but also for whole-body energy homeostasis. Research in rodents indicates that weight loss is able to improve insulin sensitivity of the brain. The current project will test this hypothesis in humans. Therefore, brain insulin sensitivity will be assessed by fMRI in combination with intranasal insulin administration, using an established protocol. Furthermore, effects of daily administration of insulin nasal spray (versus placebo) over 8 weeks will be assessed as secondary (exploratory) variables.

Conditions

Interventions

TypeNameDescription
OTHERnasal insulin
OTHERplacebo spray

Timeline

Start date
2016-12-01
Primary completion
2024-09-01
Completion
2024-12-01
First posted
2016-12-13
Last updated
2024-02-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02991365. Inclusion in this directory is not an endorsement.